Ultrasound 'Memory' imaging may reveal hidden heart ischemia

NCT ID NCT07762495

First seen Aug 13, 2026 · Last updated Aug 14, 2026 · Updated 1 time

Summary

This trial tests whether a special ultrasound technique can detect heart muscle ischemia (reduced blood flow) in people with suspected acute coronary syndrome. The approach uses microbubbles that stick to activated immune cells and blood vessel linings, potentially revealing inflammation even after the ischemia has resolved. Researchers will compare the imaging results with a final diagnosis made by an expert committee to see how accurate the test is.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Myocardial contrast echocardiography (MCE) molecular imaging with Sonazoid, a contrast agent containing microbubbles designed to stick to activated immune cells and blood vessel linings to reveal inflammation from ischemia.
What this could lead to
If it works, this could lead to a quick, bedside ultrasound test that helps doctors rapidly confirm or rule out a heart attack, potentially speeding up treatment and reducing unnecessary hospital stays.
What could go wrong
This is an early, proof-of-concept study with a small number of patients, so the imaging may not be accurate enough for routine use. There is also a small risk of allergic reactions to the contrast agent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.